ACER THERAPEUTICS INC (ACER) Earnings History & Surprises

NASDAQ:ACER • US00444P1084

Current stock price

0.9 USD
+0.03 (+3.41%)
At close:
0.8005 USD
-0.1 (-11.06%)
After Hours:

ACER Earnings overview

Past quarterly earnings results for ACER THERAPEUTICS INC (ACER), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Mar 25, 2024
Period
Q3 / 2023
EPS Estimate
-$0.13
Revenue Estimate
2.601M

Last Reported

Most Recent
Release Date
Nov 15, 2023
Period
Q2 / 2023
EPS Reported
-$0.33
EPS Surprise
-26.87%
Revenue Surprise
%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q2 2023 -0.33 -0.26 -26.87% -94.12% 306K - -
Q1 2023 -0.77 -0.29 -164.88% -20.31% - -
Q4 2022 -0.54 -0.38 -43.08% -74.19% - -100.00%
Q3 2022 -0.31 -0.70 55.52% -34.78% - -
Q2 2022 -0.17 -0.58 70.76% 26.09% - -
Q1 2022 -0.64 -0.42 -51.19% -481.82% 2.55M -100.00% -100.00%
Q4 2021 -0.31 -0.01 -2,939.22% 38.00% 360K 3.4M -89.41% -
Q3 2021 -0.23 -0.29 19.47% 54.90% - -
Q2 2021 -0.23 -0.37 37.10% 58.93% 1.02M -100.00% -
Q1 2021 -0.11 -0.45 75.36% 77.55% 4M 680.003K 488.23% -
Q4 2020 -0.50 -0.42 -20.29% - - -
Q3 2020 -0.51 -0.47 -8.70% - - -
Q2 2020 -0.56 -0.38 -45.78% - - -
Q1 2020 -0.49 -0.41 -20.10% - - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

ACER EPS Q2Q GrowthACER EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 0 -100 -200 -300 -400

Revenue Historical Q2Q growth and Acceleration

ACER Revenue Q2Q GrowthACER Revenue Q2Q GrowthRevenue Q2Q Growth Q1/22 Q4/22 -20 -40 -60 -80

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
2
Average EPS beat (4)
8.00%
Max EPS beat (4)
70.76%
Min EPS beat (4)
-51.19%

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

In the last 4 quarters, ACER has beaten EPS estimates in 2 out of 4 releases
In the last 4 quarters, ACER has beaten the EPS estimates by 8.0% on average.
ACER Overview ACER Technical Analysis Report ACER Fundamental Analysis Report ACER Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

ACER THERAPEUTICS INC / ACER Earnings FAQ

Can you provide the last earnings date for ACER THERAPEUTICS INC?

ACER THERAPEUTICS INC (ACER) last reported earnings on 11/15/2023.

Did ACER THERAPEUTICS INC (ACER) beat earnings estimates last quarter?

ACER THERAPEUTICS INC (ACER) missed EPS estimates and missed revenue estimates in the most recent quarter.

What percentage of the time does ACER stock beat earnings estimates?

In the last 4 quarters, ACER THERAPEUTICS INC (ACER) has beaten EPS estimates in 2 out of 4 releases.